Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

The challenge of quantifying and managing pharmacokinetic variability of beta-lactams in the critically ill.

Crass RL, Williams P, Roberts JA.

Anaesth Crit Care Pain Med. 2019 Dec 31. pii: S2352-5568(19)30490-4. doi: 10.1016/j.accpm.2019.12.008. [Epub ahead of print] No abstract available.

PMID:
31899302
2.

Evolution of Equations for Estimating Renal Function and Their Application to the Dosing of New Antimicrobials.

Lew AK, Crass RL, Eschenauer G.

Ann Pharmacother. 2019 Nov 24:1060028019890346. doi: 10.1177/1060028019890346. [Epub ahead of print]

PMID:
31762287
3.

Development of a sensitive LC-MS/MS method for quantification of linezolid and its primary metabolites in human serum.

Souza E, Felton J, Crass RL, Hanaya K, Pai MP.

J Pharm Biomed Anal. 2020 Jan 30;178:112968. doi: 10.1016/j.jpba.2019.112968. Epub 2019 Nov 5.

PMID:
31727360
4.

Vancomycin volume of distribution estimation in adults with class III obesity.

Dunn RD, Crass RL, Hong J, Pai MP, Krop LC.

Am J Health Syst Pharm. 2019 Dec 2;76(24):2013-2018. doi: 10.1093/ajhp/zxz241.

PMID:
31630155
5.

Reappraisal of Linezolid Dosing in Renal Impairment To Improve Safety.

Crass RL, Cojutti PG, Pai MP, Pea F.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00605-19. doi: 10.1128/AAC.00605-19. Print 2019 Aug.

6.

Optimizing Estimated Glomerular Filtration Rate to Support Adult to Pediatric Pharmacokinetic Bridging Studies in Patients with Cystic Fibrosis.

Crass RL, Pai MP.

Clin Pharmacokinet. 2019 Oct;58(10):1323-1332. doi: 10.1007/s40262-019-00761-5.

PMID:
30972695
7.

Pharmacokinetics and Pharmacodynamics of β-Lactamase Inhibitors.

Crass RL, Pai MP.

Pharmacotherapy. 2019 Feb;39(2):182-195. doi: 10.1002/phar.2210. Epub 2019 Jan 20. Review.

PMID:
30589457
8.

Curricular Reform in Pharmacy Education Through the Lens of the Flexner Report of 1910.

Crass RL, Romanelli F.

Am J Pharm Educ. 2018 Sep;82(7):6804. doi: 10.5688/ajpe6804.

9.

Daptomycin for the treatment of Staphylococcus aureus infections complicated by septic pulmonary emboli.

Crass RL, Powell KL, Huang AM.

Diagn Microbiol Infect Dis. 2019 Feb;93(2):131-135. doi: 10.1016/j.diagmicrobio.2018.09.004. Epub 2018 Sep 14. Review.

PMID:
30279024
10.

Individualizing piperacillin/tazobactam dosing in adult patients with cystic fibrosis: can tobramycin measurements help?

Crass RL, Pai MP, Lodise TP Jr.

J Antimicrob Chemother. 2019 Jan 1;74(1):126-129. doi: 10.1093/jac/dky388.

PMID:
30252050
11.

Renal Dosing of Antibiotics: Are We Jumping the Gun?

Crass RL, Rodvold KA, Mueller BA, Pai MP.

Clin Infect Dis. 2019 Apr 24;68(9):1596-1602. doi: 10.1093/cid/ciy790.

PMID:
30219824
12.

Dosing vancomycin in the super obese: less is more.

Crass RL, Dunn R, Hong J, Krop LC, Pai MP.

J Antimicrob Chemother. 2018 Nov 1;73(11):3081-3086. doi: 10.1093/jac/dky310.

PMID:
30203073
13.

Estimating Renal Function in Drug Development: Time to Take the Fork in the Road.

Crass RL, Pai MP.

J Clin Pharmacol. 2019 Feb;59(2):159-167. doi: 10.1002/jcph.1314. Epub 2018 Sep 5. Review.

PMID:
30184267
14.

Measurement of Skeletal Muscle Area Improves Estimation of Aminoglycoside Clearance across Body Size.

Crass RL, Ross BE, Derstine BA, Lichty M, Sullivan JA, Su GL, Wang SC, Pai MP.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e00441-18. doi: 10.1128/AAC.00441-18. Print 2018 Jun.

15.

Nephrotoxicity in Patients with or without Cystic Fibrosis Treated with Polymyxin B Compared to Colistin.

Crass RL, Rutter WC, Burgess DR, Martin CA, Burgess DS.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02329-16. doi: 10.1128/AAC.02329-16. Print 2017 Apr.

16.

Use of Premixed Parenteral Nutrition During a Phosphate Shortage in a Non-Critically Ill Population.

Curtis CS, Busch RA, Crass RL, Webb AP, Kudsk KA.

Nutr Clin Pract. 2016 Apr;31(2):218-22. doi: 10.1177/0884533615583093. Epub 2015 Apr 20.

Supplemental Content

Loading ...
Support Center